title: Proteomics Analysis Reveals Novel RASSF2 Interaction Partners.
abstract: RASSF2 is a tumor suppressor that shares homology with other Ras-association domain (RASSF) family members. It is a powerful pro-apoptotic K-Ras effector that is frequently inactivated in many human tumors. The exact mechanism by which RASSF2 functions is not clearly defined, but it likely acts as a scaffolding protein, modulating the activity of other pro-apoptotic effectors, thereby regulating and integrating tumor suppressor pathways. However, only a limited number of RASSF2 interacting partners have been identified to date. We used a proteomics based approach to identify additional RASSF2 interactions, and thereby gain a better insight into the mechanism of action of RASSF2. We identified several proteins, including C1QBP, Vimentin, Protein phosphatase 1G and Ribonuclease inhibitor that function in diverse biological processes, including protein post-translational modifications, epithelial-mesenchymal transition, cell migration and redox homeostasis, which have not previously been reported to interact with RASSF2. We independently validated two of these novel interactions, C1QBP and Vimentin and found that the interaction with C1QBP was enhanced by K-Ras whereas, interestingly, the Vimentin interaction was reduced by K-Ras. Additionally, RASSF2/K-Ras regulated the acetylation of Vimentin. Our data thus reveal novel mechanisms by which RASSF2 may exert its functions, several of which may be Ras-regulated.
authors.affiliation: Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40202, USA. tfbarn02@exchange.louisville.edu.
authors.forename: Thibaut
authors.initials: T
authors.lastname: Barnoud
authors.affiliation: Department of Medicine, James Graham Brown Cancer Center, Molecular Targets Program, University of Louisville, Louisville, KY 40202, USA. dwwilk02@exchange.louisville.edu.
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Wilkey
authors.affiliation: Department of Medicine, James Graham Brown Cancer Center, Molecular Targets Program, University of Louisville, Louisville, KY 40202, USA. michael.merchant@louisville.edu.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Merchant
authors.affiliation: Department of Medicine, James Graham Brown Cancer Center, Molecular Targets Program, University of Louisville, Louisville, KY 40202, USA. jennifer.clark@louisville.edu.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Clark
authors.affiliation: Department of Medicine, James Graham Brown Cancer Center, Molecular Targets Program, University of Louisville, Louisville, KY 40202, USA. howard.donninger@louisville.edu.
authors.forename: Howard
authors.initials: H
authors.lastname: Donninger
keywords: K-Ras; RASSF2; SIRT1; Vimentin; acetylation